Literature DB >> 12125959

Molecular genetic analysis of HLA-DR and -DQ alleles in Spanish patients with melanoma.

E Nagore1, M D Planelles, E Ledesma, J M Millán, A Insa, V Oliver, C Guillén, J M Fortea.   

Abstract

Controversial data have been reported about HLA alleles and susceptibility to melanoma. The relationship between distribution of HLA alleles in patients with melanoma and susceptibility to tumour was analysed, to study the possible correlation between HLA class II DQA1, DQB1 and DRBI genes and melanoma in a Spanish population. Genomic DNA from 82 patients with melanoma and 367 random healthy donors, from the same geographic area, were typed by PCR-SSP (sequence specific primers). The patients were also divided into different groups according to the age and presence of cancer relatives, and compared with the controls. None of these HLA class II alleles showed significant positive or negative associations with either the overall population of patients with melanoma or the considered subgroups. Moreover, values for relative risk of DQB1*0301, DQB1*0302, DQB1*0303, DQB*05, DQA1*0401, DQA1*0101/0104 and DRB*08, which have been reported to be increased or decreased in patients with melanoma, were very low and of no statistical significance. Our results indicate that HLA class II alleles may not contribute to a strong susceptibility to melanoma in the Spanish population, although further studies on larger series are needed to corroborate this. Key words:

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125959     DOI: 10.1080/00015550252948095

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

2.  Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.

Authors:  Helen Gogas; John M Kirkwood; Christine S Falk; Urania Dafni; Vernon K Sondak; Dimosthenis Tsoutsos; Alexandros Stratigos; Christos Markopoulos; Dimitrios Pectasides; Maria Spyropoulou-Vlachou
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

3.  HLA-DRB116:01 and HLA-DQB105:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma.

Authors:  Xu Wang; Francisco Almazan; Yoel Genaro Montoyo-Pujol; Antonia Martin-Casares; Aurelio Martin; Teresa Cabrera; Miguel Angel López-Nevot
Journal:  J Oncol       Date:  2021-09-30       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.